Healthcare Analytics, Population Health Management, Healthcare Big Data

Precision Medicine

Georgetown Offers Brain Cancer Data for Precision Medicine Research

August 16, 2018 - Georgetown Lombardi Comprehensive Cancer Center will now make its collection of brain cancer data freely available to precision medicine researchers worldwide. The dataset, called the REpository for Molecular BRAin Neoplasia DaTa (REMBRANDT), is one of only two such repositories in the country, and contains information on 671 adults from 14 contributing institutions. Thousands of...


More Articles

How Artificial Intelligence is Changing Radiology, Pathology

by Jessica Kent

Artificial intelligence and machine learning tools have the potential to analyze large datasets and extract meaningful insights to enhance patient outcomes, an ability that is proving helpful in radiology and pathology. Images obtained by...

How to Bring Precision Medicine into Routine Clinical Care

by Jessica Kent

Precision medicine has taken the healthcare industry by storm in recent years, offering the promise of more individualized treatments, improved patient outcomes, and a deeper understanding of genetic conditions and rare...

VA, IBM Watson Extend AI, Genomics Partnership for Cancer Care

by Jessica Kent

The Department of Veteran Affairs (VA) and IBM Watson Health have announced an extension of their partnership to bring artificial intelligence and genomic analytics to cancer care. The VA’s precision oncology program primarily...

UPMC, UPitt Launch Genome Sequencing Center for Medical Research

by Jessica Kent

The University of Pittsburgh Medical Center (UPMC) and the University of Pittsburgh have announced the creation of the UPMC Genome Center, an advanced genome sequencing facility that will enhance clinical diagnostics and support precision...

AARP Invests $60M in Dementia, Alzheimer’s Disease Research

by Jessica Kent

The AARP’s  Brain Health Fund will invest $60 million in the Dementia Discovery Fund (DDF) to accelerate the development of innovative treatments for dementia and Alzheimer’s disease, which have profound impacts on...

NCI Studies Link Dozens of Genetic Variants to Cancer

by Jessica Kent

The discovery of genetic variants that are associated with cancer development could assist providers with identifying high-risk patients and crafting precision medicine therapies for oncology, according to new research funded by the...

Clinical Decision Support from Dana-Farber Powers Cancer Care

by Jessica Kent

Experts at Dana-Farber Cancer Institute are partnering with Royal Philips to provide improved clinical decision support for cancer care. The incredibly complex nature of cancer, coupled with its many available treatment options, has long...

FDA: Drug Development Transparency Key for Precision Medicine

by Jessica Kent

New guidance from the FDA urges drug development stakeholders to be transparent with their data as a way to maintain high quality and foster patient-centered precision medicine.   Innovative, personalized treatments are being...

WVU Genetic Test to Improve Lung Cancer Treatment

by Jessica Kent

Researchers at the West Virginia University (WVU) Cancer Institute are developing a genetic test that will improve treatment for patients with lung cancer and help physicians determine which patients will benefit from chemotherapy and...

NIH Precision Medicine Clinical Trial Releases New Findings

by Jessica Kent

The National Cancer Institute’s Molecular Analysis for Therapy Choice (NCI-MATCH) trial, the largest precision medicine trial of its kind, has released results from several sub-studies that could bring targeted treatments to patients...

Broader Availability of Genetic Testing a Boon for Precision Care

by Jennifer Bresnick

Precision medicine is quickly moving out of the realm of science fiction and into the everyday routines of oncologists, neurologists, and other providers treating patients who may have had little hope just a few short years ago. While the...

NIH Recommends Precision Medicine Approach to Treat Alzheimer’s

by Jessica Kent

Precision medicine, big data analytics, and stakeholder collaboration could improve treatment and prevention of Alzheimer’s disease and related dementias, according to recommendations from the National Institutes of Health...

Harvard, Cancer Orgs Unite to Accelerate Precision Medicine Research

by Jessica Kent

The Harvard Business School Kraft Precision Medicine Accelerator has announced that five leading cancer organizations will come together to share best practices, engage patients, and create synergies to advance precision medicine across...

Geisinger Adds Genomic Sequencing to Routine Clinical Care

by Jessica Kent

Geisinger Health System has announced that it will soon include genomic sequencing in routine clinical care in an effort to advance precision medicine and improve patient outcomes. “Understanding the genome warning signals of every...

NIH Opens Up “All of Us” to Research Participants Nationwide

by Jessica Kent

The National Institutes of Health’s (NIH) All of Us precision medicine research program is now open to all individuals 18 and older nationwide, allowing participants across the country to contribute their data to a research resource...

LG Health, Aspire Launch $300M AI, IoT, Precision Medicine Fund

by Jessica Kent

Aspire Universal has partnered with Penn Medicine Lancaster General Health (LG Health) to introduce the Aspire Ventures Precision Medicine Fund (AVP), a $300 million initiative that will accelerate personalized device and medical practice...

Machine Learning Can Quiet “Building Crescendo” of EHR Dissatisfaction

by Jennifer Bresnick

The notion that electronic health records are difficult to work with and cumbersome to use has become a worryingly common theme across the healthcare industry.  Providers working in organizations of all sizes, settings, and...

Intermountain Launches Prospective Precision Medicine Study

by Jennifer Bresnick

Intermountain Healthcare is launching a new precision medicine project that will allow researchers to take a prospective view on the potential of genomic data. The PRECISE study allows for the collection of fresh-frozen tissue and blood...

Henry Ford to Apply Data Analytics to Pancreatic Cancer with $20M Gift

by Jennifer Bresnick

An anonymous $20 million donation to Henry Ford Health System will help the health system leverage big data analytics for the early detection and better treatment of pancreatic cancer. The Henry Ford Pancreatic Cancer Center will focus on...

X

Join 25,000 of your peers

Register for free to get access to all our articles, webcasts, white papers and exclusive interviews.

Our privacy policy

no, thanks

Continue to site...